文献速递脑血管病外科神经重症

对Hunt和Hess 3-5级不适合血管内治疗的动脉瘤性蛛网膜下腔出血的搭桥与去血管化技术:结局病例系列及与夹闭术的比较

Bypass and Deconstructive Technique for Hunt and Hess Grade 3-5 Aneurysmal Subarachnoid Hemorrhage Deemed Unfavorable for Endovascular Treatment: Case Series of Outcomes and Comparison with Clipping.
PubMed 文献 · World Neurosurg · 2020-02-24

本研究回顾性分析2013至2018年Hunt和Hess 3-5级动脉瘤性蛛网膜下腔出血患者的前瞻性数据库,比较搭桥血运重建术与直接夹闭术的并发症和功能结局。23例接受血运重建,60例接受单纯夹闭。两组30天全因死亡率(15% vs. 16%;P=0.97)及出院和随访时功能量表评分无显著差异,但血运重建组总体卒中率更高(P=0.004)。作者认为搭桥是此类高危患者可行的选择。

要点

  • Hunt和Hess 3-5级aSAH中,搭桥血运重建与直接夹闭的30天死亡率无显著差异(15% vs. 16%;P=0.97)。
  • 搭桥组总体卒中率更高(P=0.004),主要为血管内治疗相关卒中(P=0.049)。
  • 两组出院及中位8个月随访时Glasgow结局量表和改良Rankin量表评分无显著差异(P>0.67)。

核心结论

  • 搭桥是Hunt和Hess 3-5级aSAH且不适合单独血管内治疗患者的可行选择。
  • 尽管动脉瘤复杂性和卒中风险存在明显差异,血运重建的功能结局可与夹闭术相当。

研究设计与样本

  • 回顾性分析2013至2018年前瞻性数据库中Hunt和Hess 3-5级aSAH患者。
  • 比较搭桥血运重建术(23例)与直接夹闭术(60例)的并发症和功能状态。

主要发现

  • 30天全因死亡率搭桥组15% vs. 夹闭组16%(P=0.97)。
  • 出院及中位8个月随访时Glasgow结局量表和改良Rankin量表评分两组无显著差异(P>0.67)。
  • 总体卒中率搭桥组高于夹闭组(P=0.004),其中血管内治疗相关卒中差异有统计学意义(P=0.049)。
  • 手术相关卒中(P=0.47)和血管痉挛相关卒中(P=0.53)两组无差异。
  • 总体并发症、内科并发症、癫痫、再出血、脑积水和围手术期死亡两组无差异(P>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intracranial bypass to treat ruptured aneurysms has been well described in the literature but is largely deferred in patients with higher Hunt and Hess (H & H) grades due to complexity and length of surgery, risk of inducing vasospasm, and poor prognosis. However, there is a paucity of data and no direct comparison with more traditional open surgical techniques. This study investigated outcomes in patients with H & H grade 3-5 aneurysmal subarachnoid hemorrhage (aSAH) unfavorable for stand-alone endovascular treatment managed with bypass compared with direct surgical clipping. METHODS: A prospective database of patients treated for aSAH with H & H grade 3-5 between 2013 and 2018 was retrospectively analyzed. Complications and functional status at discharge and latest follow-up were compared between patients who underwent bypass surgery versus direct clipping. RESULTS: Twenty-three patients underwent revascularization, and 60 underwent clipping alone. There were no significant differences in all-cause 30-day mortality (15% vs. 16%; P = 0.97) or Glasgow Outcome Scale and modified Rankin Scale at discharge or median 8-month follow-up (P > 0.67). There was a higher overall stroke rate with revascularization (P = 0.004), specifically endovascular treatment-related stroke (P = 0.049), with no difference in surgical (P = 0.47) or vasospasm-related stroke (P = 0.53). There were no differences in overall complications, medical complications, seizures, reruptures, hydrocephalus, or perioperative death (P > 0.05). CONCLUSIONS: Bypass is a viable option for patients presenting with higher H & H grade aSAH deemed unfavorable for stand-alone endovascular therapy. Despite obvious differences in aneurysm complexity and a higher risk of stroke, functional outcomes with revascularization can be comparable with clipping in this high-risk patient cohort.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lam J, Rennert RC, Ravina K, et al. Bypass and Deconstructive Technique for Hunt and Hess Grade 3-5 Aneurysmal Subarachnoid Hemorrhage Deemed Unfavorable for Endovascular Treatment: Case Series of Outcomes and Comparison with Clipping. World Neurosurg. 2020. PMID: 32105867. doi:10.1016/j.wneu.2020.02.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。